Member LoginDividend CushionValue Trap
|
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for
any changes.
Jul 30, 2017
Dividend Increases/Decreases for the Week Ending July 28
Let's take a look at companies raising/lowering their dividends this week. Jul 27, 2017
PayPal, Facebook Post Strong Second-Quarter Results
Image shown: Facebook's traditional free cash flow (CFO less capital expenditures), in millions.Two of our favorite holdings in the Best Ideas Newsletter portfolio put up strong second-quarter results. We continue to like their respective shares. Jul 26, 2017
Boeing’s Shares Rocketing Higher
Image Source: Rob Bulmahn. Dividend Growth Newsletter portfolio holding Boeing issued second-quarter results and raised full-year 2017 guidance. We remain bullish on the commercial aerospace supply chain and defense contractors amid increasing geopolitical tensions across the globe. Jul 24, 2017
Dividend Increases/Decreases for the Week Ending July 21
Let's take a look at companies raising/lowering their dividends this week. Jul 17, 2017
Dividend Increases/Decreases for the Week Ending July 14
Let's take a look at companies raising/lowering their dividends this week. Jul 12, 2017
Important Valuentum Announcements
We have a few important announcements and a couple reminders to share. Jul 2, 2017
Prepared Remarks From Nelson Exclusive Conference Call June 30
Read President of Investment Research Brian Nelson's prepared remarks for the yearly roundup conference call, held for Nelson Exclusive members. May 24, 2017
Pipeline Woes Continue to Plague Amgen
Image Source: kibbles_bits. The commercial viability of a biotech outfit’s pipeline can often determine the future path of the share price. Irrespective of the past performance, if a company cannot innovate, it will witness its competitive position erode, leading to an inevitable decline in revenue. The latest setback from the clinical labs continues to support a bearish stance on Amgen. May 17, 2017
Volatility Spikes, Oh Cisco, the Mighty US Dollar, and More
Image Source: CBOE. Let’s talk about recent market events May 17. There’s a lot going on. May 17, 2017
Coherus Biosciences Begins the Process of Bringing a Humira Biosimilar to Market
Image Source: Drugs.com. The duration and validity of patents that back the intellectual property of drugs in the pharma/biotech industry underpin the group’s revenue stream. Once patent protection is lost, however, revenue from products typically nosedives as multi-source products come to market, undercutting their original price. The patent estate, in essence, bestows monopoly-like pricing power to Big Pharma. Once lost though, it becomes tough to replace. Let’s provide a quick update on the breaking Coherus Biosciences patent win.
prev12345678910111213141516171819202122232425
26272829303132333435363738394041424344454647484950 51525354555657next The High Yield Dividend Newsletter, Best Ideas
Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on
this website are for information purposes only and should not be considered a solicitation to buy or sell any
security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s
accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or
omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts
no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a
registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees,
and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.
|
